Jet Capital Investors LP increased T Mobile Us Inc (TMUS) stake by 25.45% reported in 2018Q4 SEC filing. Jet Capital Investors LP acquired 322,796 shares as T Mobile Us Inc (TMUS)’s stock rose 3.96%. The Jet Capital Investors LP holds 1.59M shares with $101.20 million value, up from 1.27 million last quarter. T Mobile Us Inc now has $64.27B valuation. The stock increased 1.32% or $0.98 during the last trading session, reaching $75.23. About 3.36M shares traded or 6.77% up from the average. T-Mobile US, Inc. (NYSE:TMUS) has risen 15.75% since May 11, 2018 and is uptrending. It has outperformed by 11.38% the S&P500. Some Historical TMUS News: 02/05/2018 – T-Mobile CEO Checks Into Trump Hotel on Fence-Mending DC Mission; 20/04/2018 – $VZ $T $TMUS $S all diving here; 30/04/2018 – CROWN CASTLE: AVG 5 YRS REMAINING ON T-MOBILE LEASE AGREEMENTS; 25/05/2018 – Calling All Young Visionaries! T-Mobile Changemaker Challenge Ends Soon; 24/05/2018 – DEUTSCHE TELEKOM DTEGn.DE SAYS MID-TERM PLAN DOES NOT INCLUDE PROPOSED T-MOBILE-SPRINT MERGER; 26/03/2018 – T-Mobile at Company Roadshow Hosted By equinet Bank AG Today; 09/05/2018 – Deutsche Telekom raises EBITDA guidance as T-Mobile US performs; 20/03/2018 – It’s a Steal! T-Mobile Customers Score a FREE Year of MLB.TV; 25/05/2018 – Lewandowski is getting paid by T-Mobile as part of the contract with Turnberry, according to documents reviewed by the Journal, as well as people familiar with his involvement; 08/05/2018 – Legere and Claure at FCC Again Selling T-Mobile, Sprint Merger

Sabby Management Llc increased Ophthotech Corp (OPHT) stake by 25.86% reported in 2018Q4 SEC filing. Sabby Management Llc acquired 418,640 shares as Ophthotech Corp (OPHT)’s stock declined 12.36%. The Sabby Management Llc holds 2.04 million shares with $2.45M value, up from 1.62 million last quarter. Ophthotech Corp now has $57.58 million valuation. It closed at $1.39 lastly. It is up 42.86% since May 11, 2018 and is downtrending. It has underperformed by 47.23% the S&P500. Some Historical OPHT News: 09/05/2018 – OPHTHOTECH 1Q COLLABORATION REV $0; 10/05/2018 – Municipal Employees Retire Sys Of Michigan Buys Into Ophthotech; 01/05/2018 – Ophthotech Completes Patient Recruitment in the Phase 2a Clinical Trial of Zimura(R) in Combination With Anti-VEGF Therapy in Wet Age-Related Macular Degeneration; 19/04/2018 DJ Ophthotech Corp, Inst Holders, 1Q 2018 (OPHT); 09/05/2018 – OPHTHOTECH 1Q LOSS/SHR 36C, EST. LOSS/SHR 40C (2 EST.); 09/05/2018 – Ophthotech 1Q Loss $13.1M; 01/05/2018 – Ophthotech Initial Top-line Data for Study Expected by the End of 2018; 09/05/2018 – Ophthotech 1Q Loss/Shr 36c

Investors sentiment increased to 1.3 in Q4 2018. Its up 0.19, from 1.11 in 2018Q3. It is positive, as 50 investors sold TMUS shares while 142 reduced holdings. 83 funds opened positions while 166 raised stakes. 262.95 million shares or 0.62% more from 261.32 million shares in 2018Q3 were reported. Millennium Mngmt Ltd Liability Com reported 123,297 shares. Levin Cap Strategies LP reported 5,848 shares. 20,400 were accumulated by Ellington Management Group Inc Ltd Limited Liability Company. California-based Parnassus Invests Ca has invested 0.1% in T-Mobile US, Inc. (NASDAQ:TMUS). California Public Employees Retirement invested in 0.06% or 703,733 shares. Atalanta Sosnoff Cap Limited Liability Corporation reported 0.02% stake. Maplelane Capital Ltd Liability Com accumulated 120,000 shares. Jet Capital Investors LP has invested 13.07% of its portfolio in T-Mobile US, Inc. (NASDAQ:TMUS). Jefferies Group Lc reported 66,816 shares. Tiger Eye Llc reported 3,253 shares. The Michigan-based Asset Mngmt has invested 0.04% in T-Mobile US, Inc. (NASDAQ:TMUS). Moreover, Moody Bankshares Tru Division has 0.13% invested in T-Mobile US, Inc. (NASDAQ:TMUS). Motco invested 0% in T-Mobile US, Inc. (NASDAQ:TMUS). Cubist Systematic Strategies Limited Liability Company holds 9,079 shares. S Muoio Limited Liability Corporation accumulated 6,138 shares or 0.34% of the stock.

Among 3 analysts covering T-Mobile US (NYSE:TMUS), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. T-Mobile US had 6 analyst reports since December 19, 2018 according to SRatingsIntel. The stock of T-Mobile US, Inc. (NASDAQ:TMUS) earned “Buy” rating by HSBC on Friday, March 8. On Friday, March 22 the stock rating was maintained by Guggenheim with “Buy”. The company was maintained on Wednesday, December 19 by Raymond James.

More notable recent T-Mobile US, Inc. (NASDAQ:TMUS) news were published by: Fool.com which released: “Is the T-Mobile/Sprint Deal in Trouble? – Motley Fool” on April 24, 2019, also Seekingalpha.com with their article: “Sprint Could Be Heading To $3 – Seeking Alpha” published on May 06, 2019, Investorplace.com published: “Buy Sprint Stock Ahead of the T-Mobile Merger Approval – Investorplace.com” on May 09, 2019. More interesting news about T-Mobile US, Inc. (NASDAQ:TMUS) were released by: Investorplace.com and their article: “DoJ Rhetoric Could Be Good for T-Mobile and Sprint Stock – Investorplace.com” published on April 24, 2019 as well as Seekingalpha.com‘s news article titled: “Sprint, T-Mobile chiefs meet with FCC’s Rosenworcel – Seeking Alpha” with publication date: April 22, 2019.

Jet Capital Investors LP decreased Twenty First Centy Fox Inc (NASDAQ:FOXA) stake by 481,969 shares to 2.02M valued at $97.22M in 2018Q4. It also reduced Siga Technologies Inc (SIGA) stake by 54,158 shares and now owns 3.05M shares. Disney Walt Co (Call) (NYSE:DIS) was reduced too.

More notable recent IVERIC bio, Inc. (NASDAQ:OPHT) news were published by: Seekingalpha.com which released: “Ophthotech changes name to IVERIC bio; shares up 7% premarket – Seeking Alpha” on April 16, 2019, also Nasdaq.com with their article: “IVERIC bio’s (ISEE) Q1 Loss Narrows, Gene Therapy in Focus – Nasdaq” published on May 09, 2019, Benzinga.com published: “33 Stocks Moving In Friday’s Pre-Market Session – Benzinga” on April 12, 2019. More interesting news about IVERIC bio, Inc. (NASDAQ:OPHT) were released by: Seekingalpha.com and their article: “DIS, APC among premarket gainers – Seeking Alpha” published on April 12, 2019 as well as Streetinsider.com‘s news article titled: “After-Hours Movers 04/11: (OPHT) (CGC) (BA) Higher; (XFOR) (MOS) (LYFT) (more…) – StreetInsider.com” with publication date: April 11, 2019.

Sabby Management Llc decreased Astrazeneca Plc (Put) stake by 293 shares to 3,312 valued at $12.58M in 2018Q4. It also reduced Spdr S&P Biotech (Call) stake by 1,185 shares and now owns 694 shares. Unum Therapeutics Inc was reduced too.

Investors sentiment increased to 0.81 in Q4 2018. Its up 0.02, from 0.79 in 2018Q3. It improved, as 7 investors sold OPHT shares while 19 reduced holdings. 10 funds opened positions while 11 raised stakes. 13.56 million shares or 10.31% less from 15.12 million shares in 2018Q3 were reported. Blackrock stated it has 0% in IVERIC bio, Inc. (NASDAQ:OPHT). Endurance Wealth Mgmt Inc invested in 0% or 1,500 shares. Advisory Ltd Liability stated it has 0% in IVERIC bio, Inc. (NASDAQ:OPHT). Jacobs Levy Equity Mngmt Inc holds 0.01% or 237,547 shares. Financial Bank Of America Corp De has 0% invested in IVERIC bio, Inc. (NASDAQ:OPHT) for 1,006 shares. 54,275 are held by Creative Planning. Tang Capital Limited Liability Corp reported 600,000 shares stake. Geode Management Limited Liability Com, Massachusetts-based fund reported 173,774 shares. Bankshares Of Montreal Can holds 3 shares. California Pub Employees Retirement holds 0% or 43,600 shares in its portfolio. 347,800 were accumulated by Spark Inv Management Llc. Bogle Investment Limited Partnership De stated it has 36,858 shares or 0% of all its holdings. Connor Clark And Lunn Limited holds 0.01% or 883,754 shares in its portfolio. Wells Fargo And Mn holds 39,635 shares or 0% of its portfolio. Renaissance Techs owns 0% invested in IVERIC bio, Inc. (NASDAQ:OPHT) for 736,900 shares.

Since January 2, 2019, it had 0 insider buys, and 4 selling transactions for $10,340 activity. 3,637 IVERIC bio, Inc. (NASDAQ:OPHT) shares with value of $4,510 were sold by GUYER DAVID R. Shares for $389 were sold by Westby Keith.

IVERIC bio, Inc. (NASDAQ:OPHT) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *